Igtad-MD 5 Tablet contains Tadalafil 5 mg, a selective phosphodiesterase type 5 (PDE5) inhibitor indicated primarily for the treatment of erectile dysfunction (ED) in adult males. Tadalafil works by enhancing the effects of nitric oxide, a natural chemical released during sexual stimulation, which relaxes the smooth muscles in the corpus cavernosum and increases blood flow to the penis, facilitating the achievement and maintenance of an erection. This medication is also approved for the management of benign prostatic hyperplasia (BPH) symptoms and may be used in combination with other therapies as prescribed by a healthcare professional. Igtad-MD 5 Tablet is typically administered orally, with or without food, approximately 30 minutes before anticipated sexual activity, and its effects can last up to 36 hours, allowing for greater spontaneity. The recommended dosage should not be exceeded to minimize the risk of adverse effects such as headache, dyspepsia, back pain, myalgia, nasal congestion, and flushing. Caution is advised in patients with cardiovascular conditions, those taking nitrates, or other medications that may interact with tadalafil. It is essential to consult a healthcare provider before initiating therapy to ensure safety and appropriate use.